Literature DB >> 30280285

Gallic acid activates hippocampal BDNF-Akt-mTOR signaling in chronic mild stress.

Ji-Xiao Zhu1, Jia-Ling Shan1, Wei-Qiong Hu1, Jin-Xiang Zeng1, Ji-Cheng Shu2.   

Abstract

Gallic acid (3,4,5-trihydroxybenzoic acid) is a naturally occurring polyphenolic compound. Previous study has shown that gallic acid possessed significant antidepressant-like activity in mice, which was partly mediated by increasing serotonin and catecholamine levels. The main aim of the present study is to investigate the possible effects of gallic acid on brain-derived neurotrophic factor (BDNF) signaling activation. Mice were exposed to chronic mild stress (CMS) and orally administrated with gallic acid for four weeks. The behavioral results showed that gallic acid not only reversed the decreased sucrose preference, but also attenuated the increased immobility time. In addition, gallic acid promoted both the BDNF and p-TrkB levels in the hippocampus induced by CMS. Moreover, the results also demonstrated that the inactivated Akt-mTOR signaling pathway, as well as its downstream effectors induced by CMS was activated again by gallic acid. Last, immunofluorescence detection indicated that gallic acid reversed the newborn neurons inhibition in the dentate gyrus by CMS. In conclusion, these results show that the activation of the hippocampal BDNF-Akt-mTOR signaling is involved in the antidepressant-like effects of gallic acid.

Entities:  

Keywords:  Brain-derived neurotrophic factor (BDNF); Chronic mild stress (CMS); Gallic acid

Mesh:

Substances:

Year:  2018        PMID: 30280285     DOI: 10.1007/s11011-018-0328-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  35 in total

Review 1.  Neurogenesis in the Normal Ageing Hippocampus: A Mini-Review.

Authors:  Désirée R M Seib; Ana Martin-Villalba
Journal:  Gerontology       Date:  2014-11-29       Impact factor: 5.140

2.  Chronic Supplementation of Curcumin Enhances the Efficacy of Antidepressants in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Pilot Study.

Authors:  Jing-Jie Yu; Liu-Bao Pei; Yong Zhang; Zi-Yu Wen; Jian-Li Yang
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

Review 3.  Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents.

Authors:  Ronald S Duman; Bhavya Voleti
Journal:  Trends Neurosci       Date:  2012-01       Impact factor: 13.837

4.  Exercise increases serum brain-derived neurotrophic factor in patients with major depressive disorder.

Authors:  A Kerling; M Kück; U Tegtbur; L Grams; S Weber-Spickschen; A Hanke; B Stubbs; K G Kahl
Journal:  J Affect Disord       Date:  2017-03-18       Impact factor: 4.839

5.  Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress.

Authors:  Ritu Chhillar; Dinesh Dhingra
Journal:  Fundam Clin Pharmacol       Date:  2012-03-28       Impact factor: 2.748

6.  Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.

Authors:  Denis J David; Benjamin Adam Samuels; Quentin Rainer; Jing-Wen Wang; Douglas Marsteller; Indira Mendez; Michael Drew; Douglas A Craig; Bruno P Guiard; Jean-Philippe Guilloux; Roman P Artymyshyn; Alain M Gardier; Christophe Gerald; Irina A Antonijevic; E David Leonardo; René Hen
Journal:  Neuron       Date:  2009-05-28       Impact factor: 17.173

7.  BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice.

Authors:  Li-Tao Yi; Jing Li; Bin-Bin Liu; Liu Luo; Qing Liu; Di Geng
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

8.  Antidepressants increase neural progenitor cells in the human hippocampus.

Authors:  Maura Boldrini; Mark D Underwood; René Hen; Gorazd B Rosoklija; Andrew J Dwork; J John Mann; Victoria Arango
Journal:  Neuropsychopharmacology       Date:  2009-07-15       Impact factor: 7.853

9.  Fluoxetine regulates mTOR signalling in a region-dependent manner in depression-like mice.

Authors:  Xiao-Long Liu; Liu Luo; Rong-Hao Mu; Bin-Bin Liu; Di Geng; Qing Liu; Li-Tao Yi
Journal:  Sci Rep       Date:  2015-11-02       Impact factor: 4.379

Review 10.  Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-Analyses.

Authors:  Taro Kishi; Reiji Yoshimura; Toshikazu Ikuta; Nakao Iwata
Journal:  Front Psychiatry       Date:  2018-01-17       Impact factor: 4.157

View more
  1 in total

1.  Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.

Authors:  G F Brum; H Z Rosa; D R Rossato; J L O Rosa; V G Metz; L H Milanesi; M E Burger
Journal:  Neurotox Res       Date:  2020-05-26       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.